查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575361

運動障礙市場：按類型、治療方法、給藥途徑、最終用戶分類 - 全球預測 2025-2030

Dyskinesia Market by Type (Chorea, Levodopa-Induced Dyskinesia, Myoclonus), Treatment (Medications, Surgical Procedures, Therapies), Route of Administration, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年運動障礙市場價值為 23.4 億美元，預計到 2024 年將達到 25 億美元，預計複合年成長率為 8.44%，到 2030 年將達到 41.3 億美元。

運動障礙通常與帕金森氏症和類似疾病有關，是指肌肉的不自主、不規則或急動運動。其範圍涵蓋多種疾病，包括藥物引起的運動障礙，主要與長期使用左旋多巴等藥物有關。解決運動障礙的必要性源於它對患者生活品質的重大影響，因此調查和治療至關重要。應用包括主要針對神經傳導物質系統的藥物和緩解症狀的治療設備。典型的最終使用領域包括醫院、診所和研究機構。神經系統疾病盛行率的上升、意識的提高以及醫療技術的進步推動了市場的成長。然而，不斷上漲的治療成本和與現有治療方法相關的副作用是成長的主要挑戰。個人化醫療和基因治療的創新提供了一個有前景的發展途徑，並且可以顯著影響市場動態。目前的治療機會在於開發非多巴胺能治療方案和即時追蹤症狀的穿戴式監測技術。公司可以透過積極與研究機構夥伴關係並實施人工智慧主導的研究策略來開拓尖端治療方法而受益。一項重要建議是投資綜合臨床試驗，以證明新治療方法的有效性和安全性。監管障礙和嚴格的核准流程等挑戰往往會減緩新治療方法進入市場的速度。此外，患者對治療反應的異質性可能需要更個人化的方法並使標準化工作變得複雜。治療方法的地理差異凸顯了新興市場接受治療的重要性。完美的創新領域包括了解影響神經保護策略和神經退化的微生物與腸道​​相互作用。整體而言，運動障礙市場有望成長，特別是當新的創新解決現有限制時，但要充分發揮其潛力，需要從策略上克服固有的複雜性和挑戰。

主要市場統計
基準年[2023] 23.4億美元
預測年份 [2024] 25億美元
預測年份 [2030] 41.3億美元
複合年成長率（%） 8.44%

市場動態：揭示快速發展的運動障礙市場的關鍵市場洞察

供需的動態交互作用正在改變運動障礙市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 製藥公司與研究機構合作
    • 透過增加以患者為中心的治療模式來提高治療依從性和結果
    • 治療運動障礙的微創手術技術的高需求
    • 擴大旨在減輕運動障礙症狀的新療法的管道
  • 市場限制因素
    • 深度治療費用高
  • 市場機會
    • 創新的治療性介入可改善運動障礙患者的運動表現和生活品質
    • 用於運動障礙早期檢測和進展監測的先進診斷工具和技術
    • 結合藥物和非藥理學的處置方法治療運動障礙的個人化治療計劃
  • 市場挑戰
    • 嚴格監管要求的副作用

波特的五力：駕馭運動障礙市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解運動障礙市場的外在影響

外在宏觀環境因素在塑造運動障礙市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解運動障礙市場的競爭格局

對運動障礙市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣運動障礙市場廠商績效評估

FPNV 定位矩陣是評估運動障礙市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製運動障礙市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對運動障礙市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥公司與研究機構的合作
      • 增加以病人為中心的照護模式，以提高治療順從性和結果
      • 治療運動障礙的微創手術技術的高需求
      • 擴大旨在減輕運動障礙症狀的新療法的管道
    • 抑制因素
      • 深度治療費用高
    • 機會
      • 創新的治療性介入可改善運動障礙患者的運動功能和生活品質
      • 用於早期檢測和監測運動障礙進展的先進診斷工具和技術
      • 結合藥物和非藥理學的處置方法治療運動障礙的個人化治療計劃
    • 任務
      • 嚴格的監管要求和藥物副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章運動障礙市場：依類型

  • 舞蹈病
  • 左旋多巴引起的運動障礙
  • 肌陣攣
  • 口腔面部運動障礙
  • 陣發性運動障礙
  • 遲發性運動障礙

第7章運動障礙市場的治療

  • 藥品
    • 抗膽鹼能藥物
    • 麩胺酸阻斷劑
    • 單胺轉運調節劑
  • 外科手術
    • 消融技術
    • 腦深部電刺激療法
  • 治療方法
    • 職能治療
    • 物理治療
    • 語言治療

第8章運動障礙市場：依給藥途徑

  • 可注射的
  • 口服
  • 經皮吸收貼片

第9章運動障礙市場：依最終用戶分類

  • 學術研究所
  • 居家護理
  • 醫院
  • 專科診所

第10章美洲運動障礙市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太運動障礙市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲運動障礙市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議
Product Code: MRR-535C6291879B

The Dyskinesia Market was valued at USD 2.34 billion in 2023, expected to reach USD 2.50 billion in 2024, and is projected to grow at a CAGR of 8.44%, to USD 4.13 billion by 2030.

Dyskinesia, often associated with Parkinson's disease and similar disorders, refers to involuntary, erratic, and writhing movements of muscles. Its scope covers a wide range of conditions, including drug-induced dyskinesia primarily linked to long-term use of medications like levodopa. The necessity for addressing dyskinesia arises from its significant impact on patients' quality of life, making research and treatment imperative. The application scope primarily includes pharmaceuticals targeting neurotransmitter systems and therapeutic devices offering symptom relief. Key end-use sectors include hospitals, clinics, and research institutions. Market growth is driven by rising prevalence of neurological disorders, increasing awareness, and advancements in medical technology. However, the high cost of treatment and side effects associated with existing therapies pose significant growth challenges. Innovations in personalized medicine and gene therapy offer promising avenues for development and could significantly impact market dynamics. Present opportunities lie within the development of non-dopaminergic treatment options and wearable monitoring technology for real-time symptom tracking. For businesses, actively engaging in partnerships with research institutions to pioneer cutting-edge treatments and implementing AI-driven research strategies could prove advantageous. A crucial recommendation is investing in comprehensive clinical trials to substantiate the efficacy and safety of new interventions. Challenges like regulatory hurdles and stringent approval processes often slow down market entry of novel therapies. Furthermore, the heterogeneity of patient responses to treatment necessitates more personalized approaches, which can complicate standardization efforts. Geographic disparities in treatment availability underscore the importance of expanding reach in emerging markets. The best areas for innovation include neuroprotective strategies and the exploration of microbiome-gut interactions affecting neurodegeneration. Overall, the dyskinesia market is poised for growth, particularly as new innovations address existing limitations, yet it requires strategic navigation of the inherent complexities and challenges to realize full potential.

KEY MARKET STATISTICS
Base Year [2023] USD 2.34 billion
Estimated Year [2024] USD 2.50 billion
Forecast Year [2030] USD 4.13 billion
CAGR (%) 8.44%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dyskinesia Market

The Dyskinesia Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Collaborative efforts between pharmaceutical companies and research institutions
    • Increase in patient-centric care models enhancing treatment adherence and outcomes
    • High demand for minimally invasive surgical techniques for treating dyskinesia
    • Expanding pipeline of novel therapeutic agents aimed at mitigating dyskinesia symptoms
  • Market Restraints
    • High costs of advanced treatments
  • Market Opportunities
    • Innovative therapeutic interventions for enhancing mobility and quality of life in dyskinesia patients
    • Advanced diagnostic tools and technologies for early detection and monitoring of dyskinesia progression
    • Personalized treatment plans integrating pharmacological and non-pharmacological approaches for dyskinesia management
  • Market Challenges
    • Adverse medication effects along with stringent regulatory requirements

Porter's Five Forces: A Strategic Tool for Navigating the Dyskinesia Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dyskinesia Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dyskinesia Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dyskinesia Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dyskinesia Market

A detailed market share analysis in the Dyskinesia Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dyskinesia Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dyskinesia Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dyskinesia Market

A strategic analysis of the Dyskinesia Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dyskinesia Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Acadia Pharmaceuticals Inc., Acorda Therapeutics, Inc., Adamas Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., BioArctic AB, GlaxoSmithKline plc, Intra-Cellular Therapies, Inc., Ipsen Pharma, Kyowa Kirin Co., Ltd., Lundbeck A/S, Medtronic plc, Merz Pharmaceuticals GmbH, Neurocrine Biosciences, Inc., Roche Holding AG, Sage Therapeutics, Inc., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Ultragenyx Pharmaceutical Inc., and Voyager Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the Dyskinesia Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Chorea, Levodopa-Induced Dyskinesia, Myoclonus, Orofacial Dyskinesia, Paroxysmal Dyskinesias, and Tardive Dyskinesia.
  • Based on Treatment, market is studied across Medications, Surgical Procedures, and Therapies. The Medications is further studied across Anticholinergics, Glutamate Blockers, and Monoamine Transport Modifiers. The Surgical Procedures is further studied across Ablative Techniques and Deep Brain Stimulation. The Therapies is further studied across Occupational Therapy, Physical Therapy, and Speech Therapy.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Transdermal Patches.
  • Based on End User, market is studied across Academic & Research Institutes, Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Collaborative efforts between pharmaceutical companies and research institutions
      • 5.1.1.2. Increase in patient-centric care models enhancing treatment adherence and outcomes
      • 5.1.1.3. High demand for minimally invasive surgical techniques for treating dyskinesia
      • 5.1.1.4. Expanding pipeline of novel therapeutic agents aimed at mitigating dyskinesia symptoms
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of advanced treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative therapeutic interventions for enhancing mobility and quality of life in dyskinesia patients
      • 5.1.3.2. Advanced diagnostic tools and technologies for early detection and monitoring of dyskinesia progression
      • 5.1.3.3. Personalized treatment plans integrating pharmacological and non-pharmacological approaches for dyskinesia management
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse medication effects along with stringent regulatory requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dyskinesia Market, by Type

  • 6.1. Introduction
  • 6.2. Chorea
  • 6.3. Levodopa-Induced Dyskinesia
  • 6.4. Myoclonus
  • 6.5. Orofacial Dyskinesia
  • 6.6. Paroxysmal Dyskinesias
  • 6.7. Tardive Dyskinesia

7. Dyskinesia Market, by Treatment

  • 7.1. Introduction
  • 7.2. Medications
    • 7.2.1. Anticholinergics
    • 7.2.2. Glutamate Blockers
    • 7.2.3. Monoamine Transport Modifiers
  • 7.3. Surgical Procedures
    • 7.3.1. Ablative Techniques
    • 7.3.2. Deep Brain Stimulation
  • 7.4. Therapies
    • 7.4.1. Occupational Therapy
    • 7.4.2. Physical Therapy
    • 7.4.3. Speech Therapy

8. Dyskinesia Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Transdermal Patches

9. Dyskinesia Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Homecare
  • 9.4. Hospitals
  • 9.5. Specialty Clinics

10. Americas Dyskinesia Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Dyskinesia Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Dyskinesia Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Acadia Pharmaceuticals Inc.
  • 3. Acorda Therapeutics, Inc.
  • 4. Adamas Pharmaceuticals, Inc.
  • 5. Amneal Pharmaceuticals, Inc.
  • 6. BioArctic AB
  • 7. GlaxoSmithKline plc
  • 8. Intra-Cellular Therapies, Inc.
  • 9. Ipsen Pharma
  • 10. Kyowa Kirin Co., Ltd.
  • 11. Lundbeck A/S
  • 12. Medtronic plc
  • 13. Merz Pharmaceuticals GmbH
  • 14. Neurocrine Biosciences, Inc.
  • 15. Roche Holding AG
  • 16. Sage Therapeutics, Inc.
  • 17. Sunovion Pharmaceuticals Inc.
  • 18. Teva Pharmaceutical Industries Ltd.
  • 19. Ultragenyx Pharmaceutical Inc.
  • 20. Voyager Therapeutics, Inc.

LIST OF FIGURES

  • FIGURE 1. DYSKINESIA MARKET RESEARCH PROCESS
  • FIGURE 2. DYSKINESIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DYSKINESIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DYSKINESIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DYSKINESIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DYSKINESIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DYSKINESIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DYSKINESIA MARKET DYNAMICS
  • TABLE 7. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DYSKINESIA MARKET SIZE, BY CHOREA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DYSKINESIA MARKET SIZE, BY LEVODOPA-INDUCED DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DYSKINESIA MARKET SIZE, BY MYOCLONUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DYSKINESIA MARKET SIZE, BY OROFACIAL DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DYSKINESIA MARKET SIZE, BY PAROXYSMAL DYSKINESIAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DYSKINESIA MARKET SIZE, BY TARDIVE DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DYSKINESIA MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DYSKINESIA MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DYSKINESIA MARKET SIZE, BY GLUTAMATE BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DYSKINESIA MARKET SIZE, BY MONOAMINE TRANSPORT MODIFIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DYSKINESIA MARKET SIZE, BY ABLATIVE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DYSKINESIA MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DYSKINESIA MARKET SIZE, BY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DYSKINESIA MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DYSKINESIA MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DYSKINESIA MARKET SIZE, BY SPEECH THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DYSKINESIA MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DYSKINESIA MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DYSKINESIA MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DYSKINESIA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DYSKINESIA MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DYSKINESIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DYSKINESIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 329. DYSKINESIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 330. DYSKINESIA MARKET, FPNV POSITIONING MATRIX, 2023